Procurement of a fluxion bioflux 200 microfluidic device system in support of the national institutes of health (NIH), national cancer institute (NCI), center for cancer research (CCR), laboratory…
Ended Purchase Order Awarded Last action
- Contract number
- 75N91020P00816
- Awardee
-
Fluxion Biosciences Inc. UEI QXRFWL41N789
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $53,803
Award facts
- Opportunity
-
- Procurement of a Brand Name or Equal Fluxion Bioflux 200 microfluidic device system Solicitation · 75N91020Q00146 · Posted Aug 17, 2020
- Contract value 100% obligated
- $53,803.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Alameda, CA 94502, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Fluxion Biosciences Inc. for $53,803.00 on September 21, 2020, under a total small business set-aside for procurement of a Fluxion Bioflux 200 microfluidic device system in support of the National Cancer Institute's Center for Cancer Research, Laboratory of Molecular Biology. The order is firm fixed price with an ultimate completion date of October 18, 2020. Place of performance is Alameda, California. The originating solicitation, posted August 17, 2020, with a due date of August 24, 2020, carried the same small business set-aside designation.
Description
Procurement of a fluxion bioflux 200 microfluidic device system in support of the national institutes of health (NIH), national cancer institute (NCI), center for cancer research (CCR), laboratory of molecular biology (LMB)
Quick answers
Who was awarded contract 75N91020P00816?
75N91020P00816 was awarded to Fluxion Biosciences Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2020.
How much is contract 75N91020P00816 worth?
The government has obligated $53,803 on 75N91020P00816.
Was contract 75N91020P00816 competed?
The extent of competition for 75N91020P00816 was competed under sap. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award